Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:552-557

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tamura, N.
Right arrow Articles by Nakao, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamura, N.
Right arrow Articles by Nakao, K.

(Hypertension. 1996;27:552-557.)
© 1996 American Heart Association, Inc.


Articles

cDNA Cloning and Gene Expression of Human Type I{alpha} cGMP-Dependent Protein Kinase

Naohisa Tamura; Hiroshi Itoh; Yoshihiro Ogawa; Osamu Nakagawa; Masaki Harada; Tae-Hwa Chun; Shin-ichi Suga; Takaaki Yoshimasa; Kazuwa Nakao

From the Department of Medicine and Clinical Science, Kyoto (Japan) University Graduate School of Medicine.

Correspondence to Hiroshi Itoh, MD, PhD, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606, Japan. E-mail hiito@kuhp.kyoto-u.ac.jp.

Abstract The type I cGMP-dependent protein kinase (cGK) is one of the major pathways for the cGMP cascade and has been demonstrated to inhibit platelet aggregation, relax smooth muscle cells, and control cardiocyte contractility. There are two subtypes of the type I cGK, cGKI{alpha} and cGKIß. The former is more sensitive to cGMP than the latter. In humans, cGKIß cDNA was isolated, but the full structure and tissue-specific gene expression of cGKI{alpha} have not been determined. The significance of cGK in human cardiovascular diseases has not been investigated at the molecular level. In the present study, we isolated the full-length human cGKI{alpha} cDNA (-36 to +2177; the translation start site: +1) encoding the 671–amino acid protein. Nucleotides +267 to +2177 of the isolated cDNA were identical to the corresponding nucleotides of human cGKIß cDNA. Southern blot analysis suggested that human cGKI{alpha} and cGKIß are generated by alternative splicing of a single gene assigned to chromosome 10. By Northern blot analysis, we detected abundant human cGKI{alpha} mRNA (7.0 kb) in the aorta, heart, kidneys, and adrenals. In contrast, human cGKIß mRNA (7.0 kb) was detected abundantly only in the uterus. In cultured vascular smooth muscle cells, the type I cGK mRNA concentration was reduced to 10% of the basal level by 4x10-10 mol/L platelet-derived growth factor. Angiotensin II (10-8 mol/L), transforming growth factor-ß (4x10-11 mol/L), and tumor necrosis factor-{alpha} (6x10-6 mol/L) also exhibited an inhibitory effect on type I cGK gene expression. These findings suggest a pathophysiological implication of the type I cGK in cardiovascular diseases, including hypertension and atherosclerosis.


Key Words: protein kinases • cloning, molecular • muscle, smooth, vascular • platelet-derived growth factor • angiotensin II • growth substances




This article has been cited by other articles:


Home page
Circ. Res.Home page
H. K. Surks
cGMP-Dependent Protein Kinase I and Smooth Muscle Relaxation: A Tale of Two Isoforms
Circ. Res., November 26, 2007; 101(11): 1078 - 1080.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zeng, S. Zhuang, J. Gloddek, C.-C. Tseng, G. R. Boss, and R. B. Pilz
Regulation of cGMP-dependent Protein Kinase Expression by Rho and Kruppel-like Transcription Factor-4
J. Biol. Chem., June 23, 2006; 281(25): 16951 - 16961.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Taniguchi, Y. L. Kwak, K. A. Jones, D. O. Warner, and W. J. Perkins
Nitric oxide sensitivity in pulmonary artery and airway smooth muscle: a possible role for cGMP responsiveness
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L1018 - L1027.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Sellak, C. Choi, N. Browner, and T. M. Lincoln
Upstream Stimulatory Factors (USF-1/USF-2) Regulate Human cGMP-dependent Protein Kinase I Gene Expression in Vascular Smooth Muscle Cells
J. Biol. Chem., May 6, 2005; 280(18): 18425 - 18433.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Yamamoto and N. Suzuki
Expression and Function of cGMP-dependent Protein Kinase Type I during Medaka Fish Embryogenesis
J. Biol. Chem., April 29, 2005; 280(17): 16979 - 16986.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Chang, J. A. Hypolite, M. Velez, A. Changolkar, A. J. Wein, S. Chacko, and M. E. DiSanto
Downregulation of cGMP-dependent protein kinase-1 activity in the corpus cavernosum smooth muscle of diabetic rabbits
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2004; 287(4): R950 - R960.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
N. C. Browner, H. Sellak, and T. M. Lincoln
Downregulation of cGMP-dependent protein kinase expression by inflammatory cytokines in vascular smooth muscle cells
Am J Physiol Cell Physiol, July 1, 2004; 287(1): C88 - C96.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. L. O. Buxton
Regulation of Uterine Function: a Biochemical Conundrum in the Regulation of Smooth Muscle Relaxation
Mol. Pharmacol., May 1, 2004; 65(5): 1051 - 1059.
[Abstract] [Full Text]


Home page
HypertensionHome page
X.-H. Jin, H. E. McGrath, J. J. Gildea, H. M. Siragy, R. A. Felder, and R. M. Carey
Renal Interstitial Guanosine Cyclic 3', 5'-Monophosphate Mediates Pressure-Natriuresis Via Protein Kinase G
Hypertension, May 1, 2004; 43(5): 1133 - 1139.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Richie-Jannetta, S. H. Francis, and J. D. Corbin
Dimerization of cGMP-dependent Protein Kinase I{beta} Is Mediated by an Extensive Amino-terminal Leucine Zipper Motif, and Dimerization Modulates Enzyme Function
J. Biol. Chem., December 12, 2003; 278(50): 50070 - 50079.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Schroder, G. Klein, B. Fiedler, M. Bastein, N. Schnasse, A. Hillmer, S. Ames, S. Gambaryan, H. Drexler, U. Walter, et al.
Single L-type Ca2+ channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice
Cardiovasc Res, November 1, 2003; 60(2): 268 - 277.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. Gerzanich, A. Ivanov, S. Ivanova, J. B. Yang, H. Zhou, Y. Dong, and J. M. Simard
Alternative Splicing of cGMP-Dependent Protein Kinase I in Angiotensin-Hypertension: Novel Mechanism for Nitrate Tolerance in Vascular Smooth Muscle
Circ. Res., October 31, 2003; 93(9): 805 - 812.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Wang, X. Wu, T. M. Lincoln, and J. E. Murphy-Ullrich
Expression of Constitutively Active cGMP-Dependent Protein Kinase Prevents Glucose Stimulation of Thrombospondin 1 Expression and TGF-{beta} Activity
Diabetes, August 1, 2003; 52(8): 2144 - 2150.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Yamahara, H. Itoh, T.-H. Chun, Y. Ogawa, J. Yamashita, N. Sawada, Y. Fukunaga, M. Sone, T. Yurugi-Kobayashi, K. Miyashita, et al.
Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration
PNAS, March 18, 2003; 100(6): 3404 - 3409.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. S. Murthy and H. Zhou
Selective phosphorylation of the IP3R-I in vivo by cGMP-dependent protein kinase in smooth muscle
Am J Physiol Gastrointest Liver Physiol, February 1, 2003; 284(2): G221 - G230.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Sellak, X. Yang, X. Cao, T. Cornwell, G. A. Soff, and T. Lincoln
Sp1 Transcription Factor as a Molecular Target for Nitric Oxide- and Cyclic Nucleotide-Mediated Suppression of cGMP-Dependent Protein Kinase-I{alpha} Expression in Vascular Smooth Muscle Cells
Circ. Res., March 8, 2002; 90(4): 405 - 412.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. M. Lincoln, N. Dey, and H. Sellak
Signal Transduction in Smooth Muscle: Invited Review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression
J Appl Physiol, September 1, 2001; 91(3): 1421 - 1430.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
L. Huminiecki and R. Bicknell
In Silico Cloning of Novel Endothelial-Specific Genes
Genome Res., November 1, 2000; 10(11): 1796 - 1806.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
Y.-g. Wang, M. B. Wagner, R. W. Joyner, and R. Kumar
cGMP-dependent protein kinase mediates stimulation of L-type calcium current by cGMP in rabbit atrial cells
Cardiovasc Res, November 1, 2000; 48(2): 310 - 322.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
K. A. Lucas, G. M. Pitari, S. Kazerounian, I. Ruiz-Stewart, J. Park, S. Schulz, K. P. Chepenik, and S. A. Waldman
Guanylyl Cyclases and Signaling by Cyclic GMP
Pharmacol. Rev., September 1, 2000; 52(3): 375 - 414.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. D. Browning, M. P. McShane, C. Marty, and R. D. Ye
Nitric Oxide Activation of p38 Mitogen-activated Protein Kinase in 293T Fibroblasts Requires cGMP-dependent Protein Kinase
J. Biol. Chem., January 28, 2000; 275(4): 2811 - 2816.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Kumar, R. W. Joyner, P. Komalavilas, and T. M. Lincoln
Analysis of Expression of cGMP-Dependent Protein Kinase in Rabbit Heart Cells
J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 967 - 975.
[Abstract] [Full Text]


Home page
ScienceHome page
H. K. Surks, N. Mochizuki, Y. Kasai, S. P. Georgescu, K. M. Tang, M. Ito, T. M. Lincoln, and M. E. Mendelsohn
Regulation of Myosin Phosphatase by a Specific Interaction with cGMP- Dependent Protein Kinase I
Science, November 19, 1999; 286(5444): 1583 - 1587.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
H. Ruetten, U. Zabel, W. Linz, and H. H. H. W. Schmidt
Downregulation of Soluble Guanylyl Cyclase in Young and Aging Spontaneously Hypertensive Rats
Circ. Res., September 17, 1999; 85(6): 534 - 541.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. D. Idriss, T. Gudi, D. E. Casteel, V. G. Kharitonov, R. B. Pilz, and G. R. Boss
Nitric Oxide Regulation of Gene Transcription via Soluble Guanylate Cyclase and Type I cGMP-dependent Protein Kinase
J. Biol. Chem., April 2, 1999; 274(14): 9489 - 9493.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. P. Collins and M. D. Uhler
Cyclic AMP- and Cyclic GMP-dependent Protein Kinases Differ in Their Regulation of Cyclic AMP Response Element-dependent Gene Transcription
J. Biol. Chem., March 26, 1999; 274(13): 8391 - 8404.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-D. Chiche, S. M. Schlutsmeyer, D. B. Bloch, S. M. de la Monte, J. D. Roberts Jr., G. Filippov, S. P. Janssens, A. Rosenzweig, and K. D. Bloch
Adenovirus-mediated Gene Transfer of cGMP-dependent Protein Kinase Increases the Sensitivity of Cultured Vascular Smooth Muscle Cells to the Antiproliferative and Pro-apoptotic Effects of Nitric Oxide/cGMP
J. Biol. Chem., December 18, 1998; 273(51): 34263 - 34271.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Sellak, X. Yang, X. Cao, T. Cornwell, G. A. Soff, and T. Lincoln
Sp1 Transcription Factor as a Molecular Target for Nitric Oxide- and Cyclic Nucleotide-Mediated Suppression of cGMP-Dependent Protein Kinase-I{alpha} Expression in Vascular Smooth Muscle Cells
Circ. Res., March 8, 2002; 90(4): 405 - 412.
[Abstract] [Full Text] [PDF]